Oral gefitinib plus methotrexate is not clinically superior to methotrexate for tubal ectopic pregnancy.

Published Date: 17 Feb 2023

A new study found that oral gefitinib plus parenteral methotrexate was no more clinically effective than methotrexate alone. Search results...

Read Full News

Latest News

In Maternal Health Deserts, Pharmacists Are Bridging Gaps

To address high rates of maternal and infant mortality and morbidity, pharmacists in Mississippi are stepping in to provide care and connect women with obstetric care.

Antidepressants in Pregnancy: A Nuanced Story

Continuing selective serotonin reuptake inhibitors (SSRIs) during pregnancy is associated with impaired neonatal adaptation but not with severe complications.

More Women With Gynecologic Issues Mistrust Medicine

Though medical mistrust may arise from systemic failures, clinicians can ensure patients feel heard and receive the care they need.

Donor Eggs Do Not Fully Negate Aging’s Effects on Fertility

New research challenges the assumption that donor oocytes can reset the reproductive clock.

Safe Pregnancies With RMDs Rise, but Challenges Remain

Data presented at EULAR 2026 confirm that tight disease control can lead to safe pregnancies but also expose a critical need to address male fertility and emotional care.

Miscarriage Care Model Helps Identify Modifiable Risk Sooner

A UK model finds a surprising top modifiable risk factor; patient and staff satisfaction with the model of care is high.

Todays Updates

In SCLC, Radiotherapy Plus Immunotherapy Ups Fatal Events

A lung cancer trial was stopped early due to a high rate of fatal adverse events with the addition of thoracic radiotherapy to standard maintenance immunotherapy.

Smoldering Myeloma: The Treatment Issue Is Getting Trickier

An FDA approval, striking CAR T data, and a field that can't agree on what to do next. Experts weigh in on the most contentious question in myeloma.

Todays Updates

In SCLC, Radiotherapy Plus Immunotherapy Ups Fatal Events

A lung cancer trial was stopped early due to a high rate of fatal adverse events with the addition of thoracic radiotherapy to standard maintenance immunotherapy.

Smoldering Myeloma: The Treatment Issue Is Getting Trickier

An FDA approval, striking CAR T data, and a field that can't agree on what to do next. Experts weigh in on the most contentious question in myeloma.

Latest News

To address high rates of maternal and infant mortality and morbidity, pharmacists in Mississippi are stepping in to provide care and connect women with obstetric care.

Continuing selective serotonin reuptake inhibitors (SSRIs) during pregnancy is associated with impaired neonatal adaptation but not with severe complications.

Though medical mistrust may arise from systemic failures, clinicians can ensure patients feel heard and receive the care they need.

New research challenges the assumption that donor oocytes can reset the reproductive clock.

Data presented at EULAR 2026 confirm that tight disease control can lead to safe pregnancies but also expose a critical need to address male fertility and emotional care.

A UK model finds a surprising top modifiable risk factor; patient and staff satisfaction with the model of care is high.

News All Time

Rewiring Resistance: Precision Sequencing and Mechanism-Driven Care in Platinum-Resistant Ovarian Cancer

Rewiring Resistance: Precision Sequencing and Mechanism-Driven Care in Platinum-Resistant Ovarian Cancer

What Vitamin K Shot Refusals Are Really Telling Us

We can't fact-check our way out of a trust crisis

Maternal RSV Vaccine Linked to Lower Risk of Infant Hospitalization

"This is real protection, and it really applies to all comers," researcher says

Genomic Test May Spare More Patients With Node-Positive Breast Cancer From Chemo

Experts discuss Prosigna-guided treatment decisions in high-risk early disease

Optimizing Perioperative Therapy in Triple-Negative Breast Cancer

The treatment landscape for these patients is evolving

Tailoring Treatment for Triple-Negative Breast Cancer in Older Patients

"Most of the time we undertreat," says expert

ACOG Makes Vaccine Recommendations for the First Time

A look at how the recommendations differ from the CDC

They Told Families to 'Eat Real Food.' Now They May Cut the Produce Benefit.

To make America healthy, produce in a poor child's diet should be the last thing to go

Trump's 22 Medical Specialists; Infectious Hot Tub; Ending Postpartum Hemorrhage

Health news and commentary gathered by MedPage Today staff

Upcoming Billing Change Could Make Pregnancy Pricier

ACOG says the change is crucial to accurately reflect the care ob/gyns currently provide

Drinking in Pregnancy on the Rise, CDC Data Show

Expert urges public health campaigns to share the dangers of alcohol use in pregnancy

Mitch McConnell Hospitalized; Outbreak Deaths Reach 181; iPhones and Birth Rates

Health news and commentary gathered by MedPage Today staff

U.S. Infant Mortality Rate Falls to All-Time Low, but Trails Other Wealthy Nations

Infant deaths dropped to about 19,350 last year

Studies Raise New Questions in HR-Positive, HER2-Negative Breast Cancer

Experts discuss oral SERDs, novel targeted combinations, and sequencing

FDA Alerts on Shortage of Breast Biopsy Needles

Disruptions likely to persist through 2027, agency says

Why Some Medically Safe Births Still Feel Traumatic

Modern birth narratives may prepare women for control rather than the unpredictability of labor

Recommended News For You

Healthcare AI, Meant to Save Money, Turns Out to Require a Lot of Expensive Humans

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research

Headlines About Doc Who 'Catches' Patient's Cancer Are Popping Up Again

Are ultramarathon runners really at increased risk of bowel cancer?

The Effect of Common Steroids on Cancer Treatments.

There is a 40% reduction in the risk of 9 cancers with good cardiorespiratory fitness.

WHO launches plan for free child cancer medicines

Recommended Articles For You

Precision Oncology: Personalized Medicine Shaping the Future of Cancer Care 

A Novel Gemcitabine-Releasing Intravesical System for Intermediate-Risk Non-Muscle-Invasive Bladder Cancer 

Unmasking the Hidden Symptoms of Ovarian Cancer 

Tumor Microenvironment Reprogramming Through Stromal Modulation 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The hidden costs of cancer for young survivors are derailing their financial futures

2.

Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye Cancer

3.

According to new studies, some cancer patients can safely forego radiation therapy.

4.

The majority of cancer medications that receive expedited approval end up failing confirmatory trials.

5.

Extracellular matrix pathway emerges as treatment target for pediatric cancer

1.

The Benefits of Understanding Haptoglobin High: What You Need to Know

2.

The Latest Research on Acute Promyelocytic Leukemia: Advancements in Diagnosis and Therapy 

3.

Hypercoagulable State: Factors that Contribute to Blood Clots 

4.

Liquid Biopsy in Oncology: Innovations in Cancer Detection, Monitoring, and Clinical Use

5.

Unraveling the Mysteries of Metastasis: Exploring the Latest Advances in Cancer Research

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC

2.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI

4.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion

5.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot